254 related articles for article (PubMed ID: 6747778)
1. Design control and validation of a facility for sterile clinical trial preparations.
Staines L
J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778
[No Abstract] [Full Text] [Related]
2. The influence of clean room design on product contamination.
Whyte W
J Parenter Sci Technol; 1984; 38(3):103-8. PubMed ID: 6747777
[No Abstract] [Full Text] [Related]
3. Panel discussion: Environmental sampling in an aseptic environment. III. Cross contamination control.
Elias WF
Bull Parenter Drug Assoc; 1974; 28(6):263-9. PubMed ID: 4455322
[No Abstract] [Full Text] [Related]
4. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
[TBL] [Abstract][Full Text] [Related]
5. [Validation of procedure for sterile manufacturing. Simulated distribution in containers, in a sterile area].
Arecco D; Carazzone M; Fava M
Boll Chim Farm; 1982 Oct; 121(10):493-502. PubMed ID: 7165749
[No Abstract] [Full Text] [Related]
6. Validation and routine operation of a sterile dry powder filling facility.
Prout G
J Parenter Sci Technol; 1982; 36(5):199-204. PubMed ID: 6927748
[No Abstract] [Full Text] [Related]
7. Boundary and airlock design issues in aseptic facilities.
Lorenz MR; Robinson JE
J Parenter Sci Technol; 1991; 45(6):279-85. PubMed ID: 1802984
[TBL] [Abstract][Full Text] [Related]
8. A multicentred investigation of clean air requirements for terminally sterilized pharmaceuticals.
Whyte W
J Parenter Sci Technol; 1983; 37(4):138-44. PubMed ID: 6620047
[No Abstract] [Full Text] [Related]
9. Design and operation of a new sterile manufacturing facility.
Fornabaio TA
Bull Parenter Drug Assoc; 1970; 24(3):110-8. PubMed ID: 5422900
[No Abstract] [Full Text] [Related]
10. Control of the aseptic processing environment.
Frieben WR
Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
[TBL] [Abstract][Full Text] [Related]
11. [Validation of sterile pharmaceutical production. Considerations and experiences].
Pongiluppi S
Boll Chim Farm; 1985 Jul; 124(7):293-305. PubMed ID: 4074520
[No Abstract] [Full Text] [Related]
12. [Contamination control. 1. The sterile working bench].
Wahlström L
Sven Farm Tidskr; 1966 Nov; 70(31):729-33. PubMed ID: 5979053
[No Abstract] [Full Text] [Related]
13. A new laminar flow biological contamination control hood.
Marsh RC
Bull Parenter Drug Assoc; 1970; 24(3):134-47. PubMed ID: 5422902
[No Abstract] [Full Text] [Related]
14. Microbiological validation of a new manufacturing complex for an injectable biological product.
Carroll MC; Van Pala M; Vollherbst L
J Parenter Sci Technol; 1992; 46(4):107-10. PubMed ID: 1453278
[TBL] [Abstract][Full Text] [Related]
15. Environmental microbial challenges to an aseptic Blow-Fill-Seal process--a practical study.
Jones DJ; Topping P; Sharp J
PDA J Pharm Sci Technol; 1995; 49(5):226-34. PubMed ID: 7489196
[TBL] [Abstract][Full Text] [Related]
16. [Flow of laminar air: use in sterile rooms].
Lumini E
Boll Chim Farm; 1975 Jul; 114(7):361-74. PubMed ID: 1164445
[No Abstract] [Full Text] [Related]
17. Computer-assisted evaluation of microbiological environmental control data.
Russell MP; Purdie RN; Goldsmith JA; Phillips I
J Parenter Sci Technol; 1984; 38(3):98-102. PubMed ID: 6747782
[No Abstract] [Full Text] [Related]
18. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
[No Abstract] [Full Text] [Related]
19. PDA comments: PIC draft recommendations on the inspection of isolator technology. Parenteral Drug Association.
PDA J Pharm Sci Technol; 1999; 53(3):141-7. PubMed ID: 10754704
[No Abstract] [Full Text] [Related]
20. [Microbiological in-process control in drug manufacture].
Seyfarth VH
Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
